| Description | Mediator of RNA polymerase II transcription subunit 12 (Fragment) |
| Sequence | XERKKKSTKGKKRSQPATKTEDYGMGPGRSGPYGVTVPPDLLHHPNPGSITHLNYRQGSIGLYTQNQPLPAGGPRVDPYRPVRLPMQKLPTRPTYPGVLPTTMTGVMGLEPSSYKTSVYRQQQPAVPQGQRLRQQLQQSQGMLGQSSVHQMTPSSSYGLQTSQGYTPYVSHVGLQQHTGPADPTRHLQQRPSGYVHQQAPTYGHGLTSTQRFSHQTLQQTPMISTMTPMSAQGVQAGVRSTAILPEQQQQQ |
| Length | 251 |
| Position | Kinase |
| Organism | Homo sapiens (Human) |
| Kingdom | Metazoa |
| Lineage | Eukaryota> Metazoa> Chordata> Craniata> Vertebrata> Euteleostomi> Mammalia> Eutheria> Euarchontoglires> Primates> Haplorrhini> Catarrhini> Hominidae> Homo. |
| Aromaticity | 0.06 |
| Grand average of hydropathy | -0.914 |
| Instability index | 58.47 |
| Isoelectric point | 10.30 |
| Molecular weight | 27455.60 |
| Publications | PubMed=15772651 PubMed=24129315 |
| Annotated function |
|
| GO - Cellular Component | mediator complex GO:0016592 IEA:InterPro |
| GO - Biological Function | beta-catenin binding GO:0008013 IEA:InterPro |
| GO - Biological Process |
| Binary Interactions |
| Repeats |
>MDP29252
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
3| 130.67| 36| 41| 79| 114| 1
---------------------------------------------------------------------------
33- 64 (38.34/12.48) ..............Y....GVTVP..PDLLHH.PN.PGSIThlNYRQGSIGLYT
65- 111 (56.80/21.88) QNQplpaggprvdpYR...PVRLPM.QKLPTR.PTYPGVLP..TTMTGVMGLEP
112- 153 (35.53/11.05) SSY.......ktsvYRqqqPA.VPQgQRLRQQlQQSQGMLG..Q..SSVHQMTP
---------------------------------------------------------------------------
---------------------------------------------------------------------------
No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level
3| 101.11| 22| 73| 155| 176| 3
---------------------------------------------------------------------------
155- 176 (40.38/20.43) SSY..........GLQTSQGYTPYVSHVGLQQ
192- 219 (25.44/10.21) SGYvhqqaptyghGLTSTQRF....SHQTLQQ
230- 251 (35.29/16.95) SAQ..........GVQAGVRSTAILPEQQQQQ
---------------------------------------------------------------------------
|
| Disease | breast cancer PMID:29157917 PMID:30230586 PMID:27438523 PMID:26452386 PMID:26601288 PMID:22913342 prostate cancer PMID:29157917 PMID:23836153 PMID:23661306 PMID:22610119 PMID:26924278 PMID:26383637 colon cancer PMID:23178117 PMID:29507187 renal cell carcinoma PMID:27050271 uterine tumors PMID:31520353 PMID:26383637 Uterine leiomyoma (ULM) PMID:33025089 PMID:23443020 PMID:30895261 endometrial polyps colorectal cancers PMID:24980722 phyllodes tumors PMID:25865354 PMID:30511242 extrauterine cancer PMID:25595892 uterine smooth muscle tumors PMID:28592321 colorectal cancers PMID:23132392 PMID:28183795 castration-resistant prostate cancer PMID:24938407 Breast fibroepithelial tumors PMID:26437033 fibroadenomas PMID:28513873 epithelial ovarian cancer PMID:29735544 Thyroid Cancer PMID:28634282 lung cancer PMID:28055980 renal cancer PMID:24504440 PMID:30895261 syndromic disorders Congenital heart disease PMID:30905399 cardiovascular diseases PMID:24751643 Alzheimer disease PMID:21293490 Fragile X syndrome PMID:31098807 uterine leiomyomas PMID:25615570 PMID:32094355 PMID:25106763 PMID:30619444 Blepharophimosis PMID:24715367 short humeri PMID:24715367 hirschsprung disease PMID:24715367 Goldberg-Shprintzen syndrome PMID:24715367 Opitz-Kaveggia syndrome PMID:24715367 breast fibroadenomas PMID:25106763 pelvic inflammatory disease PMID:28432313 |
| MoRF Sequence | Start | Stop |
| 1) ILKRFA | 130 | 135 |
© 2021 Shailesh Lab
Designed by Dr. Shailesh Lab & Dr. Jitendra K. Thakur Lab